Premium
Living related renal transplantation for end‐stage renal disease after liver transplantation from a brain‐dead donor
Author(s) -
KOBAYASHI TAKASHI,
OKUNO HIROSHI,
TACHIBANA MITSUHIRO,
MORI NORIKO,
YOSHIDA HIROSHI,
YAMAMOTO SHINGO,
KAMOTO TOSHIYUKI,
TERAI AKITO,
OGAWA OSAMU
Publication year - 2003
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2003.00699.x
Subject(s) - medicine , transplantation , tacrolimus , liver transplantation , cirrhosis , end stage renal disease , prednisolone , liver disease , kidney transplantation , hepatitis c , gastroenterology , urology , disease
We report a case in which a living related renal transplantation was successfully performed for end‐stage renal disease that had progressed after a liver transplantation from a brain‐dead donor for liver cirrhosis associated with type C hepatitis. Because the transplanted liver function had been excellent with the use of tacrolimus and mycophenolate mofetil, the same immunosuppressive agents with prednisolone were employed for the renal transplantation. Both grafts are functioning well without recurrence of hepatitis at 10 months after the renal transplantation. From our experience, renal transplantation should not be contraindicated even if the patient has undergone liver transplantation or has hepatitis C viral infection.